Jump Financial, LLC Chimerix Inc Transaction History

Jump Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$4.58 - $6.8 $458,458 - $680,680	-100,100 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$5.23 - $7.18 $523,523 - $718,718	100,100 New	100,100 $644,000
Q3 2021 Nov 12, 2021	SELL	$5.94 - $8.75 $632,235 - $931,323	-106,437 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$7.54 - $9.79 $802,534 - $1.04 Million	106,437 New	106,437 $851,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.